BRIEF-MediciNova to collaborate with UCLA researchers in grant-funded clinical trial of MN-166 (ibudilast) in alcohol …


May 8(Reuters) – MediciNova Inc

* Says it plans to initiate a clinical trial of MN-166 (ibudilast) in alcohol dependence and withdrawal in collaboration with researchers at the University of California, Los Angeles (UCLA)

Source text in Japanese:goo.gl/HQfWgy

Further company coverage: (Beijing Headline News)



Source link

Leave a Reply

Your email address will not be published.